Neurocrine Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,861	2,355	1,887	1,489	1,134
Revenue Growth (YoY)	21.45%	24.81%	26.76%	31.34%	8.38%
Cost of Revenue	52.1	765.1	604.7	487	342.4
Gross Profit	2,808	1,590	1,282	1,002	791.1
Selling, General & Admin	1,156	1,007	887.6	752.7	583.3
Research & Development	1,016	-	-	-	-
Operating Expenses	2,172	1,007	887.6	752.7	583.3
Operating Income	636.5	583	394.8	249	207.8
Interest Expense	-	-	-	-	-25.8
Interest & Investment Income	90.3	91	52.8	4.1	3.8
EBT Excluding Unusual Items	726.8	674	447.6	253.1	185.8
Gain (Loss) on Sale of Investments	-4	-37.1	28.4	30.8	20.9
Other Unusual Items	-	-138.4	-	-70	-
Pretax Income	705.4	486	332.1	213.9	101.4
Income Tax Expense	226.8	144.7	82.4	59.4	11.8
Net Income	478.6	341.3	249.7	154.5	89.6
Net Income to Common	478.6	341.3	249.7	154.5	89.6
Net Income Growth	40.23%	36.68%	61.62%	72.43%	-78.00%
Shares Outstanding (Basic)	100	100	98	96	95
Shares Outstanding (Diluted)	103	104	101	99	98
Shares Change (YoY)	-1.16%	2.67%	2.12%	1.02%	0.10%
EPS (Basic)	4.81	3.40	2.56	1.61	0.95
EPS (Diluted)	4.67	3.29	2.47	1.56	0.92
EPS Growth	41.95%	33.20%	58.33%	69.56%	-77.89%
Free Cash Flow	748.7	557.2	361.6	322.9	233.1
Free Cash Flow Per Share	7.30	5.37	3.58	3.27	2.38
Gross Margin	98.18%	67.52%	67.96%	67.29%	69.79%
Operating Margin	22.25%	24.75%	20.92%	16.73%	18.33%
Profit Margin	16.73%	14.49%	13.23%	10.38%	7.90%
Free Cash Flow Margin	26.17%	23.66%	19.16%	21.69%	20.57%
EBITDA	666.6	610.1	416.1	264.6	218.7
EBITDA Margin	23.30%	25.90%	22.05%	17.77%	19.29%
D&A For EBITDA	30.1	27.1	21.3	15.6	10.9
EBIT	636.5	583	394.8	249	207.8
EBIT Margin	22.25%	24.75%	20.92%	16.73%	18.33%
Effective Tax Rate	32.15%	29.77%	24.81%	27.77%	11.64%
Revenue as Reported	2,861	2,355	1,887	1,489	1,134
Advertising Expenses	-	191	159.9	149.7	139.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.